BIWEEKLY DOCETAXEL-CISPLATIN IN CHEMO-NAIVE PATIENTS WITH ADVANCED SQUAMOUS CARCINOMA OF THE LUNG: A GALICIAN LUNG CANCER GROUP PHASE II STUDY

被引：0
|
作者：
Lazaro, Martin [1 ]
Vazquez, S. [2 ]
Jose Villanueva, Maria [3 ]
Firvida, J. L.
Amenedo, Margarita [4 ]
Afonso, Javier
Senin, Clara [3 ]
Campos, Begona
Huidobro, Gerardo [3 ]
Areses, Carmen [5 ]
机构：
[1] Complexo Hosp Univ, La Coruna, Spain
[2] Hosp Univ Lucus Augusti, Lugo, Spain
[3] Complexo Hosp Univ Vigo, Vigo, Spain
[4] Ctr Oncol Galicia, Galicia, Spain
[5] Complexo Hosp Univ Santiago De Compostela, Santiago De Compostela, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
non-squamous; cisplatin; docetaxel;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1278 / S1279
页数：2
相关论文
共 50 条
  • [21] A Galician Lung Cancer Group phase II study of bevacizumab (B), cisplatin, and vinorelbine in chemotherapy-naive patients (p) with non-squamous non-small cell lung cancer (NSCLC)
    Leon, L.
    Vazquez, S.
    Gracia, J.
    Casal, J.
    Lazaro, M.
    Firvida, J. L.
    Amenedo, M.
    santome, L.
    Cardona, J. V.
    Macia, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [22] BEVACIZUMAB (B), CISPLATIN (C) AND PEMETREXED (P) PLUS MAINTENANCE B IN CHEMO-NAiVE PATIENTS (PTS) WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSNSCLC): A PHASE II STUDY
    Lopez Vivanco, G.
    Carrera Revilla, S.
    Sancho Gutierrez, A.
    Marrodan Ciordia, I.
    Azkona Uribelarrea, E.
    Iruarrizaga Ovejas, E.
    Rubio Etxebarria, I.
    Cardona, J. V.
    Munoz Llerena, A.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S72 - S72
  • [23] Biweekly docetaxel and vinorelbine as second-line treatment in advanced (stage IIIB+ IV) non-small-cell lung cancer (NSCLC).: A phase II study of the Galician Lung Cancer Group
    Vázquez, S
    Villanueva, M
    Amenedo, M
    Fírvida, J
    Lázaro, M
    Del Rio, L
    Huidobro, G
    Mei, J
    Ramos, M
    Grande, C
    LUNG CANCER, 2005, 49 : S273 - S273
  • [24] Biweekly paclitaxel as second-line treatment in advanced non-small-cell-lung-cancer (NSCLC).: A phase II study of the Galician Lung Cancer Group
    Vazquez-Estevez, S.
    Firvida, J. L.
    Grande, C.
    Baron, F.
    Lazaro, M.
    Salgado, M.
    Campos, B.
    Casal, J.
    Perez, E.
    Mel, J. R.
    EJC SUPPLEMENTS, 2007, 5 (04): : 392 - 392
  • [25] Phase I and pharmacologic study of weekly gemcitabine and paclitaxel in chemo-naive patients with advanced non-small-cell lung cancer
    De Pas, T
    de Braud, F
    Danesi, R
    Sessa, C
    Catania, C
    Curigliano, G
    Fogli, S
    del Tacca, M
    Zampino, G
    Sbanotto, A
    Rocca, A
    Cinieri, S
    Marrocco, E
    Milani, A
    Goldhirsch, A
    ANNALS OF ONCOLOGY, 2000, 11 (07) : 821 - 827
  • [26] Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer:: a lung cancer Galician group phase II study
    Casal, Joaquin
    Amenedo, Margarita
    Mel, Jose Ramon
    Anton, Luis Miguel
    Rodriguez-Lopez, Ruben
    Lopez-Lopez, Rafael
    Gonzalez-Ageitos, Ana
    Castellanos, Javier
    Constenla, Manuel
    Tisaire, Jose L.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (05) : 725 - 732
  • [27] Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: a lung cancer Galician group phase II study
    Joaquín Casal
    Margarita Amenedo
    José Ramón Mel
    Luis Miguel Antón
    Rubén Rodríguez-López
    Rafael López-López
    Ana González-Ageitos
    Javier Castellanos
    Manuel Constenla
    José L. Tisaire
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 725 - 732
  • [28] Phase I study of paclitaxel, carboplatin and UFT in chemo-naive patients with advanced non-small cell lung cancer (NSCLC)
    Yasushi Ono
    Mitsunori Hino
    Yuka Ueda
    Ryoko Kamizuru
    Masatoshi Omata
    Takashi Uehara
    Yosuke Tanaka
    Tomoyuki Soma
    Shoji Kudoh
    Medical Oncology, 2007, 24 : 402 - 406
  • [29] A phase II randomized study of paclitaxel plus carboplatin or cisplatin against chemo-naive inoperable non-small cell lung cancer in the elderly
    Chen, Yuh-Min
    Perng, Reury-Perng
    Tsai, Chun-Ming
    Whang-Peng, Jacqueline
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (02) : 141 - 145
  • [30] Phase I study of paclitaxel, carboplatin and UFT in chemo-naive patients with advanced non-small cell lung cancer (NSCLC)
    Ono, Yasushi
    Hino, Mitsunori
    Ueda, Yuka
    Kamizuru, Ryoko
    Omata, Masatoshi
    Uehara, Takashi
    Tanaka, Yosuke
    Soma, Tomoyuki
    Kudoh, Shoji
    MEDICAL ONCOLOGY, 2007, 24 (04) : 402 - 406
12345